Genomic Vision Announces the Approval by Its Shareholders' M

Regulatory News: Genomic Vision(FR0011799907 GV the "Company"), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, informs its

Related Keywords

Paris , France General , France , Bagneux , Dominique Remy Renou , Strategic Communications , Euronext , Regulatory News , Extraordinary Shareholder Meeting , Des Meuniers , Investors General , Genomic Vision , Genomic , Vision , Nnounces , Approval , Shareholders , Meeting , Resolutions , Upported , Executive , Board ,